Form D · Agriculture
Hobart Biosciences Holdings Inc.
Hobart, OK · CIK 0001940979
Offering snapshot reported Aug 9, 2022 · SEC filing
- Reported sold
- $0 Offering amount: $3.71M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 12, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 9, 2022 | Initial | $0 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b, 4a5
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-455297
Source: Form D, filed Aug 9, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kenneth John Bachman | Director |
| Kevin Neilson | Director |
| Sheldon Robinson | Director, Executive |
| Paul Williams | Director, Executive |
Issuer details
Industry: Agriculture (See others in industry)
Address:
711 W 9 Th St
Hobart, OK, 73651
Hobart, OK, 73651